American Shared Hospital Services posts $7.62M revenue, misses EPS

American Shared Hospital Services reported third-quarter revenue of $7.62 million and a loss of $0.09 per share (EPS), against consensus estimates of $8.53 million and $0.01, respectively. The revenue shortfall was $910,000, while EPS missed by $0.10. The healthcare services company released the results Thursday, according to Zacks.

What drove the earnings miss?

On its conference call, management said third-quarter revenue rose 6.3% to $7.6 million. Direct Patient Services revenue increased 13.6%, while Gamma Knife procedure volume rose about 11% in both the quarter and the first nine months. Direct Patient Services revenue for the first nine months increased 27%.

Gross margin fell 2.2 percentage points to 19.9% from 22.1%. EBITDA (earnings before interest, taxes, depreciation and amortization) declined to $1.4 million from $1.9 million. Net loss widened to $620,000, while net margin stood at -5.83%. Return on equity (ROE), profit measured against shareholder equity, was -6.52%.

Management also said nine-month EBITDA and net income declined as operating and financing-related costs increased. Revenue growth did not translate into stronger profitability.

What does the debt position mean for growth?

American Shared Hospital Services had $9.5 million in cash and restricted cash versus $15.6 million in current debt, a $6.1 million difference. The company operates under a forbearance agreement with Fifth Third Bank through June 30, 2027. Forbearance gives the company temporary relief from some debt enforcement while the lender and borrower negotiate.

The chairman’s newly formed company also provided $2 million in subordinated financing, which ranks behind senior debt for repayment. The debt balance exceeds cash and restricted cash by $6.1 million, and financing terms still constrain the company’s options.

Which expansion projects are moving?

Management is designing two Rhode Island projects and expects its Guadalajara Gamma Knife joint venture to begin treating patients in mid-2027.

For the Rhode Island proton therapy project, the company is pursuing an “asset-light approach,” which limits the capital and equipment it commits to the venture. It also said it is “limiting other growth efforts” until it resolves its lender relationship.

The project pipeline extends into 2027, but broader expansion remains tied to a resolution with lenders.

How did the shares trade?

• Shares rose 0.1% to $1.09 in Friday midday trading, though the quoted dollar change rounded to $0.00.
• Trading volume totaled 1,605 shares, compared with an average of 84,564.
• The price sat below the 50-day moving average of $1.33 and the 200-day moving average of $1.58.
• Market capitalization stood at $7.26 million. The price-to-earnings ratio was -4.36, and beta, a measure of volatility relative to the broader market, was 0.29.
• The 12-month trading range ran from $0.98 to $2.39.

Trading was light, and the negative price-to-earnings ratio was consistent with the reported loss.

What does the company do?

American Shared Hospital Services provides hospitals and healthcare providers with access to advanced radiation oncology and other medical technologies. It supplies equipment, financing, management and operational support through hospital-based and outpatient arrangements.

The company has historically specialized in Gamma Knife stereotactic radiosurgery systems, which treat certain brain disorders and tumors without conventional surgery. The central finance test is whether higher treatment activity can outpace operating and financing costs while the company resolves its debt position.